<DOC>
	<DOCNO>NCT00841854</DOCNO>
	<brief_summary>At present , triple therapy recommend various guideline treatment Helicobacter pylorus ( H. pylorus ) infection . Recent study show worldwide high treatment failure rate one week first line clarithromycin base triple therapy necessitate salvage strategy eradicate H. pylori primary treatment failure . However , exact duration bismuth base second line treatment determine . Therefore , investigator perform study evaluate eradication rate 1 2-week quadruple regimen second-line therapy .</brief_summary>
	<brief_title>Comparison 7-day 14-day Bismuth Based Quadruple Therapy Secondary Helicobacter Pylori Eradication</brief_title>
	<detailed_description />
	<mesh_term>Helicobacter Infections</mesh_term>
	<mesh_term>Bismuth</mesh_term>
	<mesh_term>Pantoprazole</mesh_term>
	<mesh_term>Tetracycline</mesh_term>
	<mesh_term>Metronidazole</mesh_term>
	<criteria>H. pylori infection Aged 1880 year Are willing received eradication therapy H. pylori Children teenager age less 18 year 80 year Previous eradication therapy H. pylori History gastrectomy Previous allergic reaction antibiotic Use prompt pump inhibitor antibiotics recent 4 week Active upper GI bleeding recent 1 week Contraindication treatment drug Pregnant lactate woman Severe concurrent disease malignancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Helicobacter pylorus</keyword>
	<keyword>Bismuth</keyword>
	<keyword>Salvage treatment</keyword>
	<keyword>Metronidazole</keyword>
</DOC>